AI Drug Discovery & Molecule Design Software
Recursion
AI biotech with cellular imaging and automation
- SF Score
- 8.1/10
- Pricing
- Contact sales
Compare tools
2 of 4 tools selected
AI Drug Discovery & Molecule Design Software
BenevolentAI
AI drug discovery using biomedical knowledge graphs
- SF Score
- 7.8/10
- Pricing
- Contact sales
Add third toolCompare up to 4 side by side
Compare features, strengths, trade-offs, and best-fit use cases.
Comparing
Where each one leads
Read straight from the published figures below — not a ranking, and not a recommendation.
Highest SF Score
Recursion8.1/10
2 of 2 are scored
At a glance
The short version
The facts each tool publishes, lined up so you can scan down a column. Anything the catalog does not establish is marked as such rather than counted against the tool.
Recursion
- SF Score
- 8.1 / 10
- Free plan
- Not offered
- Category
- AI Healthcare & Medical Software › AI Drug Discovery & Molecule Design Software
BenevolentAI
- SF Score
- 7.8 / 10
- Free plan
- Not offered
- Category
- AI Healthcare & Medical Software › AI Drug Discovery & Molecule Design Software
Key differences
Where these tools actually diverge
The decision dimensions that separate this set, with each tool's own position stated plainly. No winner is declared — fit depends on your workflow.
Positioned for
Recursion
AI Drug Discovery & Molecule Design Software
BenevolentAI
AI Drug Discovery & Molecule Design Software
Pricing model
Recursion
Contact sales
BenevolentAI
Contact sales
SoftFinders Score
Recursion
8.1 / 10
BenevolentAI
7.8 / 10
Feature comparison
Capability matrix
Grouped by area. Every state carries a word as well as a colour, and anything the catalog has not established stays neutral rather than counting as a missing feature.
1 row differs 4 identical
| Capability | | |
|---|---|---|
| Overview | ||
| SF Score | 8.1 / 10Value | 7.8 / 10Value |
| Pricing model | CustomValue | CustomValue |
| Free plan | No | No |
| Category | AI Healthcare & Medical Software › AI Drug Discovery & Molecule Design SoftwareValue | AI Healthcare & Medical Software › AI Drug Discovery & Molecule Design SoftwareValue |
| Core features | ||
| Virtual ScreeningScreens potential drug compounds against biological targets | Yes | Yes |
Scroll the matrix sideways to see every column.
Listed by one tool only
8 capabilities are published by a single tool in this set. That does not mean the others lack them — only that the catalog has not established an answer either way.
- Literature IntelligenceMines biomedical literature for relevant evidence
- Multi OmicsIntegrates genomic and other omics data sources
- Partner WorkflowsWorkflows for pharma partner collaborations
- Target DiscoveryIdentifies potential drug targets from biological data
- Lab IntegrationConnects discovery insights with wet-lab workflows
- Molecule DesignGenerates and ranks potential drug molecules
- Protein ModelingPredicts and designs protein structures
- Knowledge GraphConnects biomedical data to uncover new insights
Use cases
What each tool is built for
The workflows each tool publishes for itself. Cards appear only for tools that list use cases.
Recursion
- Run virtual screens against targets
- Collaborate with pharma partners
- Bridge AI design and wet-lab cycles
- Identify drug targets from biology data
- Accelerate molecule design cycles
+1 more on the Recursion profile
BenevolentAI
- Accelerate molecule design cycles
- Support protein engineering programs
- Mine literature for research signals
- Run virtual screens against targets
- Collaborate with pharma partners
+1 more on the BenevolentAI profile
Pros & cons
Strengths and compromises
Each tool's published strengths and the compromises that come with them, as supplied — not scored or ranked against each other. Longer lists fold; nothing is left out.
Recursion
Pros
- Phenomics platform with extensive multimodal data
- Active pharma collaborations and internal pipeline
- Public company with transparent disclosures
Cons
- Direct buyer access remains limited to partnerships
- Drug development cycles can take many years
- Recursion's brand is evolving through Exscientia integration
BenevolentAI
Pros
- Knowledge graph-powered target discovery
- Analyzes biomedical research and biological data
- Recognized AI platform for drug discovery
- Integrates diverse biomedical data sources
- Combines AI with scientific expertise
- Supports hypothesis-driven target discovery
Cons
- Long-term company strategy has evolved
- Available through partnerships rather than self-service
- Drug discoveries still require laboratory validation
- Platform capabilities are primarily research-focused
- Public pricing information is unavailable
- Requires substantial data curation and processing
- Drug discoveries still require experimental validation
Pricing
What each one costs
Published pricing signals only. Where a tool has not established a price, that is what it says — never a zero and never "free".
Recursion
- Model
- Custom
Contact Sales
See full pricingBenevolentAI
- Model
- Custom
Contact Sales
See full pricingNext step
Ready to try one?
A matrix narrows the field; a free trial settles it. Open whichever tool fits your workflow best, or start a different comparison.
Compare another set of tools